Article Text

Download PDFPDF
Prospective cohort study
Use of oral contraceptives is not associated with increased risk of death in the UK; a net benefit in all-cause mortality was seen in ever users versus never users – RR 0.88, 95% CI 0.82 to 0.93
  1. Jane Clarke
  1. School of Medicine, University of Auckland, Auckland, New Zealand
  1. Correspondence to Jane Clarke
    Faculty of Medical and Health Sciences, School of Medicine, University of Auckland, Private Bag 92019, Auckland, New Zealand; j.clarke{at}auckland.ac.nz

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text

The combined oral contraceptive pill (OCP) was first used in 1956 in Puerto Rico and is frequently referred to as ‘the Pill’. It is a combination of oral oestrogen and a progestin (progestogen) taken for contraception by over 100 million women worldwide. The OCPs were perceived as a convenient, effective and reversible means of contraception. Ever since OCPs were first introduced, their relative safety has been the focus of much debate.1 Concerns are derived from the influences that these hormone-based therapies are used upon a …

View Full Text

Footnotes

  • Competing interests None.